期刊文献+

GATA-3在哮喘大鼠肺组织中的表达及地塞米松对其表达的影响

The Experimental Study on the Expression of Transcription Factor GATA-3 and the Effects of Dexamethasone on the Expression of GATA in the Pulmonary Tissue of Asthma
下载PDF
导出
摘要 目的探讨转录因子 GATA-3在哮喘大鼠模型肺组织中的表达及其气道炎症中的作用,并观察地塞米松对 GA-TA-3的表达及气道炎症的影响。方法 30只 Wista 大鼠随机分为3组(正常对照组,哮喘组,地塞米松治疗组),常规方法制作哮喘模型,并用地塞米松进行治疗,用免疫组化检测肺组织 GATA-3的表达,用 HE 染色的方法观察肺组织气道炎症的改变。结果与正常对照组比,哮喘组大鼠肺组织中 GATA-3的表达明显增加(P<0.05),同时气道粘膜和周围肺组织内可见明显的嗜酸粒细胞浸润。地塞米松能明显降低大鼠肺组织中 GATA-3的表达及气道炎症反应。结论转录因子 GATA-3在哮喘大鼠肺组织中的过度表达可能参与了哮喘气道炎症的发生及病理过程。 Objective To observe the expression of GATA-3 in the pulmonary tissue and its roles in the airway inflammation of asthmate models of Wistar rat.Methods Wistar rats were selected to make the model of asthma.They were divided into three groups(asthma group,nor- mal control group,dexamethasone group).The expression of GATA-3 were evalued by immunohistochemistry,and HE staining were used to detect the inflammatory cell infiltration and the inflammatory state of airway.Results The number of GATA-3 positive cells,numerical density on area,and average optical density(OD)value are significantly higher in pulmonary tissue of asthma group than that of normal control group, there am significant differences between the two groupe(P<0.01,respectively).And dexamethasone could reduce significantly the expression of GATA-3 and the inflammatory reaction in pulmonary tissue.Conclusion The over-expression of transcription factor GATA-3 might con- tribute to the pathology and the inflammatory reaction of airway in pulmonary tissue.
出处 《医学研究通讯》 2005年第6期42-44,共3页 Bulletin of Medical Research
  • 相关文献

参考文献4

二级参考文献23

  • 1全国慢性支气管炎临床专业会议修订.慢性支气管炎临床诊断及疗效判断标准[J].中华结核和呼吸杂志,1980,3(1):61-61.
  • 2Herz U,Gerhold K,Gruber C,et al.BCG infection suppresses allergi c sensitization and development of increased airway reactivity in an a nimal model.J Allergy Clin Immunol,1998,12:867-875.
  • 3Noguchi E, Shibasaki M, Arinami T, et al.Association of asthma and the interleukin-4 promoter gene in Japanese. Clin Exp Allergy, 1998, 28: 44 9-453.
  • 4Hijazi Z, Haider MZ.Interleukin-4 gene promoter polymorphism a nd asthma in Kuwaiti Arabs. Int Arch Allergy Immunol, 2000, 122: 190-194.
  • 5Burchard EG, Silverman EK, Rosenwasser LJ, et al.Association be tween a sequence variant in the IL-4 gene promoter and FEV1 in asthma.Am J Reap ir Crit Care Med, 1999, 160: 919-922.
  • 6Lazarus M, Hajeer A, Tu rner D, et al.Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus.J Rheumatol, 1997, 74: 2314-2317.
  • 7Mok CC, Lanchbury JS, Chan DW, et al.Interleukin-10 promoter polymorp hisms in Southern Chinese patients with system lupus erythematosus.Arthritis Rh eum, 1998, 41: P1090-1095.
  • 8Sanford AJ, Chagani T, Zhu S, et al.Polymorphisms in the IL-4, IL-4R A and Fc ε RI β genes and asthma severity .J Allergy Clin Immunol, 2000, 106: 135-140.
  • 9Zhu S, Chan YM, Becker AB, et al.Polymorphisms of the IL-4, TNF-α a nd Fc ε RI β genes and the risks of allergic disorders in at-risk infants.Am J Respir Crit Care, 2000, 161: P1655-1659.
  • 10Rosenwasser LJ,Borish L.Genetics of atopy and asthma: the rationale be hind promoter-based candidate gene studies(IL-4 and IL-10).Am J Respir Crit C are Med, 1997, 156: S152-155.

共引文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部